Any contraindication to Xeloda

Received Xeloda in the 6 days prior to Day 1

Subjects with organ allografts (other than autologous bone marrow transplant after high dose chemotherapy)

Renal impairment

Pregnant or lactating females

Participation in an investigational drug study within 28 days prior to screening

Lack of physical integrity of the upper gastrointestinal tract, or clinically significant malabsorption syndrome

Serious uncontrolled intercurrent infections

History of clinically significant coronary artery disease

Concomitant treatment with warfarin

Known dihydropyrimidine dehydrogenase deficiency

A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours